Skip to main navigation Skip to search Skip to main content

Matrix Metalloproteinase-responsive Iridium(III)-based Hydrogels for Tumor Cell-specific Imaging, Anti-metastasis, and Lysosome-targeted Photodynamic Therapy

Research output: Conference PapersRGC 33 - Other conference paperpeer-review

Abstract

Many cancer cells have elevated matrix metalloproteinases (MMPs) levels, which are closely implicated in tumor growth and invasion. The most common MMP-related anticancer approach was the development of MMP-sensitive materials for stimuli-responsive drug release. Herein, we report the synthesis and characterization of MMP-sensitive iridium(III)-based PEG-peptide hydrogels through the inverse electron-demand Diels–Alder (IEDDA) reaction of a PEG polymer bearing four tetrazine units with an MMP-sensitive peptide containing two bicyclo[6.1.0]nonyne units in both ends and an iridium(III) bis-tetrazine complex (Figure 1). Upon degradation of the hydrogels by the MMPs excreted from the cancer cells, the iridium(III) complex fragments were subsequently released. Their (photo)cytotoxic effect on cancer cells and inhibition effects on cell migration and invasion were studied using laser-scanning confocal microscopy.
Original languageEnglish
Publication statusPresented - 17 Mar 2025
EventLSCCB International Conference 2025 for Drug Discovery and Development - Hyatt Regency Sha Tin, Hong Kong, China
Duration: 17 Mar 202519 Mar 2025
https://www.lsccb-lc2025.com/

Conference

ConferenceLSCCB International Conference 2025 for Drug Discovery and Development
PlaceHong Kong, China
Period17/03/2519/03/25
Internet address

Funding

We thank the Hong Kong Research Grants Council (CityU11302820)for financial support. We also thank the funding support from “Laboratory for Synthetic Chemistry and Chemical Biology "under the Health @ inoHK Program".

RGC Funding Information

  • RGC-funded

Fingerprint

Dive into the research topics of 'Matrix Metalloproteinase-responsive Iridium(III)-based Hydrogels for Tumor Cell-specific Imaging, Anti-metastasis, and Lysosome-targeted Photodynamic Therapy'. Together they form a unique fingerprint.

Cite this